Form EFFECT Deciphera Pharmaceutical
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 10, 2022 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crexendo, Inc. to Issue First Quarter 2024 Financial Results on May 7, 2024, at 4:30 PM EST
- Martinrea International Inc. Announces Investment in Equispheres Inc., a Supplier of High-Performance Powders for Additive Manufacturing
- ROHM’s New Energy-Saving DC-DC Converter ICs Offered in the TSOT23 Package
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
